ImmunityBio’s Promising Preclinical HIV Drug is Moving into Phase I Trials

Promising preclinical results of ImmunityBio’s HIV drug in monkeys (specifically rhesus macaques) were presented at the 2020 Conference on Retroviruses and Opportunistic Infections (CROI) in early March.